41 studies found for:    Open Studies | "Myositis"
Show Display Options
Rank Status Study
21 Recruiting An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene;   Drug: Placebo
22 Recruiting A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva
Intervention:
23 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
24 Recruiting Dermatomyositis and Polymyositis Registry
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Acthar
25 Recruiting Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Condition: Polymyositis
Interventions: Drug: Placebo;   Drug: BAF312
26 Unknown  Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Betamethasone;   Drug: isotonic sodium chloride solution (placebo)
27 Unknown  Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
Condition: Juvenile Dermatomyositis
Interventions: Drug: 3 MPDN pulse + PDN;   Drug: 3 MPDN pulse + PDN + CSA;   Drug: 3 MPDN pulse + PDN + MTX
28 Not yet recruiting Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Conditions: Osteoporosis;   Juvenile Rheumatoid Arthritis;   Dermatomyositis;   Polyarthritis;   Systemic Lupus Erythematosis;   Vasculitis;   Glucocorticoid-induced Osteoporosis
Intervention: Drug: denosumab
29 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculitis With Onset in Infancy (SAVI)
Intervention: Drug: Baricitinib
30 Unknown  Creatine Supplementation in Pediatric Rheumatology
Conditions: Juvenile Systemic Lupus Erythematosus;   Juvenile Dermatomyositis
Interventions: Dietary Supplement: creatine;   Dietary Supplement: placebo (dextrose)
31 Recruiting Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis
Condition: Dermatomyositis Associated Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM));   Drug: Sodium thiosulfate
32 Recruiting Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Juvenile Dermatomyositis
Intervention: Drug: Human papilloma virus vaccine (cervarix)
33 Unknown  Abatacept Treatment in Polymyositis and Dermatomyositis
Conditions: Polymyositis;   Dermatomyositis
Intervention: Drug: Abatacept
34 Recruiting Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Adrenocorticotropic Hormone Gel
35 Recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: placebo
36 Not yet recruiting Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
Condition: Dermatomyositis
Intervention: Drug: Immunoglobulin (Hizentra)
37 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
38 Not yet recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
39 Recruiting Safety and Efficacy of BAF312 in Dermatomyositis
Condition: Active Dermatomyositis
Interventions: Drug: BAF312 0.5 mg;   Drug: BAF312 2 mg;   Drug: BAF312 10 mg;   Drug: Placebo to BAF312
40 Recruiting Comparative Autoantibody and Immunologic Cell Marker Study
Conditions: Autoimmune Diseases;   Lupus Erythematosus, Systemic;   Communicable Diseases
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years